GS0051: pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inflammatory and ultrasound gels, pain and gastrointestinal disorders treatment medicines, and anti-inflammatory, antimicrobial, and antifungal treatment medicines; medicines for the treatment of cardiovascular diseases and disorders, colitis, muscle spasm, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; antibiotics; pharmaceutical products for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders having vancomycin, enalapril, lisinopril, and methotrexate as the active pharmaceutical ingredient; antacids; muscle relaxants; hormone replacement medicines; topical anti-inflammatory and ultrasound gels; pharmaceutical preparation for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders, and for the treatment and prevention of renal, oncological, inflammatory, gastrointestinal, gastroesophageal, and cardio-vascular diseases and disorders
Case File Event Statements
5/3/2022 - 3 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
5/4/2022 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
1/10/2023 - 2 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
1/18/2023 - 2 years ago
4 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
2/1/2023 - 2 years ago
5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
4/18/2023 - 2 years ago
8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
2/21/2023 - 2 years ago
6 - PUBLISHED FOR OPPOSITIONType:PUBO
2/21/2023 - 2 years ago
7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
2/21/2024 - a year ago
15 - SOU EXTENSION 2 GRANTEDType:EX2G
2/22/2024 - a year ago
16 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
10/6/2023 - 2 years ago
9 - SOU TEAS EXTENSION RECEIVEDType:EEXT
10/6/2023 - 2 years ago
10 - SOU EXTENSION 1 FILEDType:EXT1
10/6/2023 - 2 years ago
11 - SOU EXTENSION 1 GRANTEDType:EX1G
10/10/2023 - 2 years ago
12 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
2/21/2024 - a year ago
13 - SOU TEAS EXTENSION RECEIVEDType:EEXT
2/21/2024 - a year ago
14 - SOU EXTENSION 2 FILEDType:EXT2
10/16/2024 - a year ago
17 - SOU TEAS EXTENSION RECEIVEDType:EEXT
10/16/2024 - a year ago
20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
10/16/2024 - a year ago
18 - SOU EXTENSION 3 FILEDType:EXT3
2/19/2025 - 8 months ago
21 - TEAS STATEMENT OF USE RECEIVEDType:EISU
4/4/2025 - 7 months ago
22 - SOU TEAS EXTENSION RECEIVEDType:EEXT
7/21/2025 - 3 months ago
25 - SOU EXTENSION 4 GRANTEDType:EX4G
7/22/2025 - 3 months ago
26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
7/21/2025 - 3 months ago
23 - CASE ASSIGNED TO INTENT TO USE PARALEGALType:AITU